Rheumatic Myocarditis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rheumatic Myocarditis Treatment Landscape

Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

CryoLife Inc.
Edwards Lifesciences Corporation
Neovasc Inc.
HighLife SAS
Abbott Laboratories
Sanofi-aventis Groupe
Pfizer Inc.
Boston Scientific Corporation
Medtronic PLC

Browse Key Market Insights with Data Illustration:

Rheumatic Myocarditis Treatment Market Size, Growth Forecasts 2025-2037

In the News

Siemens Healthcare GmbH has launched the technologically-advanced multidisciplinary angiography system ARTIS icono. With its development, the company is expected to cater to different needs of cardiovascular interventions, interventional radiology, neuroradiology, and vascular interventions.
Pfizer Inc. has finally acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company that is dedicated to the discovery, development, and delivery of life-changing treatments for patients diagnosed with sickle cell disease (SCD). The acquisition is anticipated to broaden the offerings provided by the company.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of rheumatic myocarditis treatment is assessed at USD 1.19 billion.

The rheumatic myocarditis treatment market size was over USD 1.1 billion in 2024 and is projected to reach USD 2.05 billion by 2037, growing at around 4.9% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of rheumatic fever and the growing availability of over-the-counter drugs will boost the market growth.

North America industry is likely to account for largest revenue share of 35% by 2037, propelled by increasing frequency of rheumatic fever and subsequently rheumatic myocarditis amongst several people, driven by rising awareness about the disease among people and high healthcare expenditure for treatment procedures.

The major players in the market are Siemens Healthcare GmbH, CryoLife Inc., Edwards Lifesciences Corporation, Neovasc Inc., HighLife SAS, Abbott Laboratories, Sanofi-aventis Groupe, Pfizer Inc., Boston Scientific Corporation, Medtronic PLC

Rheumatic Myocarditis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rheumatic Myocarditis Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the rheumatic myocarditis treatment market worth?

Why is the demand for rheumatic myocarditis treatment growing?

Which region dominated the majority of rheumatic myocarditis treatment industry share?

Who are the top rheumatic myocarditis treatment companies?